Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
3(18%)
Results Posted
75%(6 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_1
1
6%
Ph phase_2
7
41%
Ph phase_3
2
12%
Ph not_applicable
3
18%
Ph phase_4
4
24%

Phase Distribution

1

Early Stage

7

Mid Stage

6

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
7(41.2%)
Phase 3Large-scale testing
2(11.8%)
Phase 4Post-market surveillance
4(23.5%)
N/ANon-phased studies
3(17.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

72.7%

8 of 11 finished

Non-Completion Rate

27.3%

3 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(3)
Completed(8)
Terminated(3)
Other(3)

Detailed Status

Completed8
Recruiting3
unknown3
Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 27 (41.2%)
Phase 32 (11.8%)
Phase 44 (23.5%)
N/A3 (17.6%)

Trials by Status

recruiting318%
terminated212%
unknown318%
withdrawn16%
completed847%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT03540758Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Recruiting
NCT05934409Not Applicable

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery

Recruiting
NCT06991712Phase 2

Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients

Recruiting
NCT02808182Not Applicable

Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)

Completed
NCT03685773Phase 2

The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients

Withdrawn
NCT03510884Phase 3

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Completed
NCT01803594Not Applicable

Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) Metabolism

Completed
NCT03510715Phase 3

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia

Completed
NCT01083329Phase 2

Effect of Nicotinic Acid on Adipose Tissue Inflammation in Obese Subjects

Completed
NCT00500045Phase 2

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Terminated
NCT02890992Phase 2

An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Completed
NCT00493064Phase 2

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

Completed
NCT02642159Phase 4

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

Completed
NCT01450410Phase 4

Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDL

Terminated
NCT00712049Phase 4

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)

Unknown
NCT00238004Phase 4

The Low HDL On Six Weeks Statin Therapy (LOW) Study

Unknown
NCT00176020Phase 1

Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17